Vaccine pipeline

Imophoron is currently working on ADDomer based vaccines for three diseases, respiratory syncytial virus (RSV), Covid-19 and Chikungunya. The RSV candidate is the lead program and the company is working towards generating the pre-clinical data to support a Phase 1 clinical trial.